BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou R, Jiang F, Cai H, Zeng Q, Yang H. Case Report: Antibodies to the N-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis. Front Immunol 2021;12:664364. [PMID: 33968065 DOI: 10.3389/fimmu.2021.664364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu P, Yan H, Li H, Zhang C, Li Y. Overlapping anti-NMDAR encephalitis and multiple sclerosis: A case report and literature review. Front Immunol 2023;14:1088801. [PMID: 36793718 DOI: 10.3389/fimmu.2023.1088801] [Reference Citation Analysis]
2 Sabet MF, Barman S, Beller M, Meuth SG, Melzer N, Aktas O, Goebels N, Prozorovski T. Myelinating Co-Culture as a Model to Study Anti-NMDAR Neurotoxicity. Int J Mol Sci 2022;24. [PMID: 36613687 DOI: 10.3390/ijms24010248] [Reference Citation Analysis]
3 Zhang S, Yang Y, Liu W, Li Z, Li J, Zhou D. Clinical Characteristics of Anti-N-Methyl-d-Aspartate Receptor Encephalitis Overlapping with Demyelinating Diseases: A Review. Front Immunol 2022;13:857443. [DOI: 10.3389/fimmu.2022.857443] [Reference Citation Analysis]